Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Obeso, J. A.
Right arrow Articles by Rodriguez-Diaz, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Obeso, J. A.
Right arrow Articles by Rodriguez-Diaz, M.
NEUROLOGY 2004;62:S17-S30
© 2004 American Academy of Neurology

Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology.

The origin of motor fluctuations in Parkinson’s disease

Importance of dopaminergic innervation and basal ganglia circuits

J. A. Obeso, MD PhD, M. Rodriguez-Oroz, MD PhD, C. Marin, MD PhD, F. Alonso, MD1, I. Zamarbide, MD, J. L. Lanciego, MD PhD and M. Rodriguez-Diaz, MD PhD

Departments of Neurology and Neurosurgery and Histology, Neuroscience Center (Drs. Obeso, Rodriguez-Oroz, Alonso, Zamarbide and Lanciego), FIMA, Clinica Universitaria and Medical School, University of Navarra, Pamplona, Spain; Experimental Neurology Laboratory, Fundacio Clinic-Hospital Clinic (Dr. Marin), IDIBAG, Barcelona, Spain; and Department of Physiology, Medical School (Dr. Rodriguez-Diaz), University of La Laguna, Tenerife, Spain.

Address correspondence and reprint requests to Dr. Jose Obeso, Neurologia-Neurociencias, Clinica Universitaria, Avenida Pio XII 36, Pamplona 31180, Spain.

The severity of dopamine depletion and the consequent pathophysiologic changes that occur in basal ganglia circuits determine the severity of parkinsonian signs. Restoring the dopamine deficit or the downstream physiologic abnormalities improves Parkinson’s Disease (PD) main motor features and as a result, attenuates the short-duration response (SDR). Therefore, both the magnitude and duration of the motor response are a function of the degree of motor severity, which is primarily governed by the loss of tonic dopaminergic activity and disruption of basal ganglia homeostatic mechanisms among which the STN-GPe/GPi circuits play a fundamental role. As neurodegeneration advances, standard levodopa administration give rises to wider oscillations in striatal dopamine availability and "pulsatile" stimulation of striatal dopamine receptors becomes predominant. This induces molecular and physiologic changes that further accentuate and aggravate the SDR that sustains motor fluctuations. Treatments capable of providing and restoring more tonic and physiologic dopaminergic stimulation may avoid many of these abnormalities and lead to better clinical outcomes.


1Present address: Servicio de Neurologia, Fundacion Jimenez Diaz, Clinica de la Concepcion, Madrid, Spain.




This article has been cited by other articles:


Home page
Therapeutic Advances in Neurological DisordersHome page
O.K. Sujith and C. Lane
Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
Therapeutic Advances in Neurological Disorders, March 1, 2009; 2(2): 105 - 113.
[Abstract] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
I. Morales, J. G. Dopico, M. Sabate, T. Gonzalez-Hernandez, and M. Rodriguez
Substantia nigra osmoregulation: taurine and ATP involvement
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1934 - C1941.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. G. Androulidakis, A. A. Kuhn, C. Chu Chen, P. Blomstedt, F. Kempf, A. Kupsch, G.-H. Schneider, L. Doyle, P. Dowsey-Limousin, M. I. Hariz, et al.
Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease
Brain, February 1, 2007; 130(2): 457 - 468.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
A. McGregor and J. Wheless
Pediatric Experience With Sudden Unexplained Death in Epilepsy at a Tertiary Epilepsy Center
J Child Neurol, September 1, 2006; 21(9): 782 - 787.
[Abstract] [PDF]


Home page
BrainHome page
F. Alonso-Frech, I. Zamarbide, M. Alegre, M. C. Rodriguez-Oroz, J. Guridi, M. Manrique, M. Valencia, J. Artieda, and J. A. Obeso
Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease
Brain, July 1, 2006; 129(7): 1748 - 1757.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
R. D. Sheth and B. E. Gidal
Topical Review: Optimizing Epilepsy Management in Teenagers
J Child Neurol, April 1, 2006; 21(4): 273 - 279.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.